Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4
Some formulations (Wegovy, Saxenda) are also FDA-approved for weight management in adolescents aged 12 years and older
Clinical trials of FDA-approved GLP-1 medications have shown average weight loss of roughly 15 to 20 percent over about a year, depending on the drug and dose
Tirzepatide mimics two hormones naturally produced in the body: glucagon-like peptide-1, or GLP-1, and glucose-dependent insulinotropic polypeptide (GIP)
Since metabolic health and mental health are closely linked, GLP-1s may provide a dual benefit for individuals struggling with both obesity and depression
These medications are often recommended for individuals with a body mass index (BMI) of 30 or greater, or a BMI of 27 or greater with obesity-related health conditions
US$ 27.55
US$ 26.49
US$ 22.89
US$ 24.37
